Scarica l'app Stockscreener
4.68
7.87%
-0.40
Dopo l'orario di chiusura:
4.68
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ADPT Giù?
Forum
Previsione
Precedente Chiudi:
$5.08
Aprire:
$5.01
Volume 24 ore:
1.38M
Relative Volume:
1.35
Capitalizzazione di mercato:
$737.90M
Reddito:
$170.28M
Utile/perdita netta:
$-225.25M
Rapporto P/E:
-3.5188
EPS:
-1.33
Flusso di cassa netto:
$-167.02M
1 W Prestazione:
-27.89%
1M Prestazione:
+0.00%
6M Prestazione:
+29.64%
1 anno Prestazione:
+8.58%
Intervallo 1D:
$4.66
$5.10
Intervallo di 1 settimana:
$4.66
$6.49
Portata 52W:
$2.28
$6.70
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
Nome
Adaptive Biotechnologies Corp
Settore
Industria
Telefono
206-659-0067
Indirizzo
1165 EASTLAKE AVE E, SEATTLE, WA
Confronta ADPT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| ADPT | 4.68 | 737.90M | 170.28M | -225.25M | -167.02M | -1.33 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-12-21 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Underperform |
| 2022-06-03 | Iniziato | Piper Sandler | Neutral |
| 2022-02-16 | Reiterato | BTIG Research | Buy |
| 2022-02-16 | Reiterato | BofA Securities | Buy |
| 2022-02-16 | Reiterato | Goldman | Neutral |
| 2022-02-16 | Reiterato | JP Morgan | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-03-03 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-08 | Ripresa | BTIG Research | Buy |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-06-03 | Iniziato | Goldman | Buy |
| 2019-07-23 | Iniziato | BTIG Research | Buy |
| 2019-07-22 | Iniziato | BofA/Merrill | Buy |
| 2019-07-22 | Iniziato | Cowen | Outperform |
| 2019-07-22 | Iniziato | Goldman | Neutral |
| 2019-07-22 | Iniziato | Guggenheim | Buy |
| 2019-07-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Adaptive Biotechnologies Corp Borsa (ADPT) Ultime notizie
Adaptive Biotechnologies Corp: Is ADPT Stock Worth Buying? - Stocks Register
What is William Blair's Estimate for ADPT FY2024 Earnings? - MarketBeat
Short Interest in Adaptive Biotechnologies Co. (NASDAQ:ADPT) Declines By 5.5% - MarketBeat
Rubric Capital Management LP's Strategic Acquisition in Adaptive Biotechnologies Corp - GuruFocus.com
Matrix Capital Management Reduces Stake in Adaptive Biotechnologies Corp - GuruFocus.com
Adaptive Biotechnologies (NASDAQ:ADPT) Trading Up 12.7% Following Analyst Upgrade - Defense World
Adaptive Biotechnologies (NASDAQ:ADPT) Trading 12.7% Higher After Analyst Upgrade - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $7.00 - MarketBeat
ADPT (Adaptive Biotechnologies) Cash From Other Investing A - GuruFocus.com
Adaptive Biotechnologies Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q3 2024 Earnings Call Transcript - Insider Monkey
Nikko Asset Management Americas, Inc. Expands Stake in Adaptive Biotechnologies Corp - GuruFocus.com
Earnings call: Adaptive Biotechnologies posts robust MRD revenue growth - Investing.com
ARK Investment Management LLC Buys 189,134 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - MarketBeat
Adaptive Biotechnologies (ADPT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings Call Highl - GuruFocus.com
Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings Call Highlights: Strong MRD Growth Amidst ... - Yahoo Finance
ADPT stock touches 52-week high at $5.81 amid biotech rally By Investing.com - Investing.com South Africa
ADPT stock touches 52-week high at $5.81 amid biotech rally - Investing.com Canada
Adaptive Biotechnologies earnings beat by $0.07, revenue topped estimates - Investing.com
Adaptive Biotechnologies : Q3 2024 Earnings Presentation - Marketscreener.com
Adaptive Biotechnologies: Q3 Earnings Snapshot - CT Insider
ADPTAdaptive Biotechnologies Corporation Latest Stock News & Market Updates - StockTitan
Adaptive Biotechnologies Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings: Revenue S - GuruFocus.com
Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results - Yahoo Finance
Medicare expands coverage for MRD test in lymphoma - Investing.com
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma - Yahoo Finance
ADPT (Adaptive Biotechnologies) Total Stockholders Equity : $241.6 Mil (As of Jun. 2024) - GuruFocus.com
Earnings To Watch: Adaptive Biotechnologies Corp (ADPT) Reports Q3 2024 Result - GuruFocus.com
Sumitomo Mitsui Trust Group's Strategic Acquisition in Adaptive Biotechnologies - GuruFocus.com
Vanguard Group Inc's Strategic Acquisition in Adaptive Biotechno - GuruFocus.com
November 2024's Top US Penny Stocks With Growth Potential - Yahoo Finance
ADPT (Adaptive Biotechnologies) Cyclically Adjusted Book pe - GuruFocus.com
Adaptive Biotechnologies (ADPT) Scheduled to Post Earnings on Thursday - MarketBeat
Cancer Immunotherapy Global Market 2024 To Reach $175.39Billion By 2028 At Rate Of 12.1% - EIN News
Cancer Immunotherapy Global Market 2024 To Reach $175.39 Billion By 2028 At Rate Of 12.1% - EIN News
ADPT (Adaptive Biotechnologies) PE Ratio : At Loss (As of Oct. 30, 2024) - GuruFocus.com
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Receives $7.00 Consensus Price Target from Analysts - MarketBeat
Perhaps timely catching Adaptive Biotechnologies Corp (ADPT) would be a good idea - SETE News
Adaptive Biotechnologies Corp [ADPT] Stock sold by Insider Taylor Stacy L for $0.12 million - Knox Daily
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap UpStill a Buy? - MarketBeat
Stock Surge: Adaptive Biotechnologies Corp (ADPT) Closes at 4.94, Marking a 0.61 Increase/Decrease - The Dwinnex
Should investors be concerned about Adaptive Biotechnologies Corp (ADPT)? - US Post News
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap DownTime to Sell? - MarketBeat
Insider Selling: Taylor Stacy L, Adaptive Biotechnologies Corp [ADPT] SVP and General Counsel divested 26,922 shares – Knox Daily - Knox Daily
ADPT’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Adaptive Biotechnologies (NASDAQ:ADPT) Trading Down 4.8%Here's Why - MarketBeat
Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024 - Yahoo Finance
Adaptive Biotechnologies (STU:1HM) Momentum Rank : 8 (As of Oct. 09, 2024) - GuruFocus.com
Adaptive Biotechnologies Corp Azioni (ADPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):